HCPCS code J9024 — Inj atezolizumb 5mg hya-tqjs. Status: Active. Effective Apr 1, 2025. Source: CMS HCPCS Level II.

J9024

Active

Inj atezolizumb 5mg hya-tqjs

Injection, atezolizumab, 5 mg and hyaluronidase-tqjs

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Apr 1, 2025
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 2073

MUE — Medically Unlikely Edits

Maximum units of J9024 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 375
Outpatient Hospital 375
Practitioner Services 375

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
50242-0933-01 Tecentriq Hybreza

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q2
    Inj atezolizumb 5mg hya-tqjs